Middle
Selected Science News Highlights of 2018
As 2019 approaches, NIAID reflects on a productive year of allergic, immunologic, autoimmune and infectious disease research advances. View a slideshow highlighting selected NIAID science news from 2018.
Middle
Ebola Treatment Trial Begins in the DRC
A randomized, controlled Phase 2/3 trial testing multiple investigational Ebola therapies is enrolling patients with Ebola in the Democratic Republic of the Congo.
Middle
World AIDS Day 2018
Each year on World AIDS Day, we reflect on the remarkable progress that has been made against HIV. Indeed, we have come a long way since the disease now known as AIDS was first reported in 1981.
